Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomasz Rakowski

Showing results (1-10 of 204) with videos related to

Pageof 21
Sort By:
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|April 19, 2021
Circulating biomarkers as predictors of left ventricular remodeling after myocardial infarctionMichał Węgiel, Tomasz Rakowski
Sleep Medicine|September 25, 2025
The galectin-3/NLRP3 inflammasome axis: A unifying mechanism linking insomnia and heart failureArtur Dziewierz, Natalia Maruszak, Tomasz Rakowski
Minerva Cardioangiologica|October 21, 2016
A myocardial infarction in a patient with previous myocardial revascularization presenting with tachyarrhythmia. Is it type 1, 2 or 4c myocardial infarction?Beata Bobrowska, Tomasz Rakowski, Artur Dziewierz
Diabetes|September 26, 2013
Comment on: Tessari et al. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes 2013;62:2699-2708Olga Kruszelnicka, Tomasz Rakowski, Andrzej Surdacki
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 11, 2025
Inflammation as a foundational cardiovascular risk factor: Limitations and context of the study by Zuo et alArtur Dziewierz, Natalia Maruszak, Tomasz Rakowski
Minerva Cardioangiologica|September 27, 2016
A myocardial infarction in a patient with previous myocardial revascularization presenting with tachyarrhythmia. Is it type 1, 2 or 4c myocardial infarction?Beata Bobrowska, Tomasz Rakowski, Artur Dziewierz
Research and Practice in Thrombosis and Haemostasis|January 26, 2026
"DOACs for Left Ventricular Thrombus: Persistent Equipoise Despite New Observational and Randomized Data": commentArtur Dziewierz, Piotr Jarosz, Tomasz Rakowski
Therapeutics and Clinical Risk Management|July 30, 2014
Abciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectivesArtur Dziewierz, Tomasz Rakowski, Dariusz Dudek
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 6, 2026
The Red Cell Distribution Width/Albumin Ratio in STEMI: Biologically Plausible but Clinically UnprovenArtur Dziewierz, Michał Węgiel, Tomasz Rakowski
Heart, Lung & Circulation|January 8, 2026
Albumin-Bilirubin Score for Contrast-Induced Acute Kidney Injury Prediction in STEMI: Critical LimitationsArtur Dziewierz, Michał Węgiel, Tomasz Rakowski
Pageof 21

Showing results (1-10 of 204) with videos related to

Sort By:
Pageof 21
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|April 19, 2021
Circulating biomarkers as predictors of left ventricular remodeling after myocardial infarctionMichał Węgiel, Tomasz Rakowski
Sleep Medicine|September 25, 2025
The galectin-3/NLRP3 inflammasome axis: A unifying mechanism linking insomnia and heart failureArtur Dziewierz, Natalia Maruszak, Tomasz Rakowski
Minerva Cardioangiologica|October 21, 2016
A myocardial infarction in a patient with previous myocardial revascularization presenting with tachyarrhythmia. Is it type 1, 2 or 4c myocardial infarction?Beata Bobrowska, Tomasz Rakowski, Artur Dziewierz
Diabetes|September 26, 2013
Comment on: Tessari et al. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes 2013;62:2699-2708Olga Kruszelnicka, Tomasz Rakowski, Andrzej Surdacki
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 11, 2025
Inflammation as a foundational cardiovascular risk factor: Limitations and context of the study by Zuo et alArtur Dziewierz, Natalia Maruszak, Tomasz Rakowski
Minerva Cardioangiologica|September 27, 2016
A myocardial infarction in a patient with previous myocardial revascularization presenting with tachyarrhythmia. Is it type 1, 2 or 4c myocardial infarction?Beata Bobrowska, Tomasz Rakowski, Artur Dziewierz
Research and Practice in Thrombosis and Haemostasis|January 26, 2026
"DOACs for Left Ventricular Thrombus: Persistent Equipoise Despite New Observational and Randomized Data": commentArtur Dziewierz, Piotr Jarosz, Tomasz Rakowski
Therapeutics and Clinical Risk Management|July 30, 2014
Abciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectivesArtur Dziewierz, Tomasz Rakowski, Dariusz Dudek
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 6, 2026
The Red Cell Distribution Width/Albumin Ratio in STEMI: Biologically Plausible but Clinically UnprovenArtur Dziewierz, Michał Węgiel, Tomasz Rakowski
Heart, Lung & Circulation|January 8, 2026
Albumin-Bilirubin Score for Contrast-Induced Acute Kidney Injury Prediction in STEMI: Critical LimitationsArtur Dziewierz, Michał Węgiel, Tomasz Rakowski
Pageof 21